Futura Medical plc (LON:FUM – Get Free Report) rose 10.3% during trading on Wednesday . The stock traded as high as GBX 40.60 ($0.51) and last traded at GBX 40.60 ($0.51). Approximately 784,037 shares changed hands during mid-day trading, a decline of 10% from the average daily volume of 875,064 shares. The stock had previously closed at GBX 36.80 ($0.46).
Futura Medical Stock Performance
The firm has a 50 day simple moving average of GBX 38.47 and a 200 day simple moving average of GBX 34.60. The firm has a market cap of £123.59 million, a P/E ratio of -2,030.00 and a beta of 1.26.
Futura Medical Company Profile
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
Featured Stories
- Five stocks we like better than Futura Medical
- The 3 Best Fintech Stocks to Buy Now
- Garmin Navigates to New Highs Driven By Wearables Trend
- Consumer Discretionary Stocks Explained
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- What is the Nikkei 225 index?
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.